Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin vs Rivaroxaban in Lower Limb DVT
NCT07077954Phase 1Completed
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban in deep vein thrombosis (DVT) (2 arms), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Primary endpoint: Percentage of Recanalized Segments at 12 weeks. Started Jan 2023; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT07077954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07077954.